Home › Funds › Rubicon Founders LLC › AGL

Rubicon Founders LLC position in AGL

AGILON HEALTH INC · Health Care

Rubicon Founders LLC reported holding 105,341 shares of AGL (AGILON HEALTH INC) in its Q2 2026 13F filing — a position valued at US$11.3M, representing 5.75% of its reported portfolio and ranking #3 among its reported holdings. Rubicon Founders LLC has disclosed AGL holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)105.34K sh
Reported value held$11.29M
Portfolio Weight5.75%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Rubicon Founders LLC's AGL position evolved

Rubicon Founders LLC first disclosed a stake in AGL in Q1 2025 at 6,190,265 shares (US$26.8M). The position peaked in Q4 2025 at 6,292,396 shares, worth US$4.33B. Across 6 filings, Rubicon Founders LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 105,341 shares valued at US$11.3M — a reduction of -146,354 shares quarter over quarter.. Notable position changes include a 96% trim in Q1 2026 (shares rose 1255% over the following quarter), a 58% trim in Q2 2026 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 6.19M $26.80M New
Q2 2025 6.29M $14.47M Add
Q3 2025 6.29M $6.48M Hold
Q4 2025 6.29M $4.33B Hold
Q1 2026 251.69K $1.99M Reduce
Q2 2026 105.34K $11.29M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AGL and 13F data

AGL (AGILON HEALTH INC) is a Health Care company. 37 other funds we track also report a position in AGL — the largest reported positions include Clayton, Dubilier & Rice, LLC (US$428.7M), North Peak Capital Management, LLC (US$159.2M), Durable Capital Partners LP (US$47.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AGL

All AGL fund holders →

FAQ

How long has Rubicon Founders LLC held AGL?

Rubicon Founders LLC has disclosed AGL holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Rubicon Founders LLC's current position in AGL?

As of Q2 2026, Rubicon Founders LLC holds 105.34K shares of AGL (AGILON HEALTH INC), valued at $11.29M, representing 5.75% of its reported portfolio and ranking #3.

Has Rubicon Founders LLC been buying or selling AGL?

In the latest 13F filing (Q2 2026), Rubicon Founders LLC reduced its position in AGL. The position peaked in Q4 2025 at 6.29M shares.

Which other funds hold AGL?

Other major institutional holders of AGL include Clayton, Dubilier & Rice, LLC, North Peak Capital Management, LLC, Durable Capital Partners LP, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.